ANRO Stock Price - Alto Neuroscience, Inc. logo

ANRO Stock Price

Alto Neuroscience, Inc.

$25.51
-$0.40(-1.54%)
44
Overall
60
Value
41
Tech
31
Quality
How is this score calculated?
Market Cap
$999.16M
Volume
213.41K
52W Range
$12.51 - $37.48
Target Price
$38.22

ANRO stock price is $25.51 (-1.54% on the day), giving Alto Neuroscience, Inc. a market cap of $999.16M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

ANRO Stock Overview

Price
$25.51
Previous close
$25.91
Open
$26.20
Market cap
$999.16M
52-week range
$12.51 - $37.48
1-year price target
$38.22
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
MarketXLS Rank
44

About Alto Neuroscience, Inc.

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline comprising ALTO-100, which is in phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties which is in phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor which is in phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist which is in phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor which is in phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.

ABCD
1SymbolPriceChangeVol
2ANRO$25.51-1.5%213.41K
3
4
5
6

Get Alto Neuroscience, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.